COIOSDeep risk insights through multi-disciplinary research across the globe
A store shelf filled with lots of milk
Item new Peer-reviewed Added

Atrial fibrillation recurrence after ablation was similar on GLP-1, SGLT2 or both

Among adults having catheter ablation for atrial fibrillation, recurrence was similar on a GLP-1 drug, an SGLT2 inhibitor or both, while all-cause mortality was lower on the combination.

Adults undergoing catheter ablation for atrial fibrillation in the TriNetX network were grouped by use of a GLP-1 drug, an SGLT2 inhibitor or both. Recurrence after the three-month blanking period was similar in all three matched comparisons. All-cause mortality was lower on the combination, with hazard ratios of 0.54 against a GLP-1 drug alone and 0.60 against an SGLT2 inhibitor alone.

Why it is interesting: The arrhythmia outcome shows no difference, yet mortality does, on wide intervals in routine records.

Source
Heart Rhythm, 17 September 2026
Paper
The Effect of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors Alone and in Combination on AF Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation
Authors
Ramadan A, Doma M, Yazdanpanah MH, Naeem F, Ptaszek LM, Ruskin JN
DOI
10.1016/j.hrthm.2026.09.018
Type
Peer-reviewed article
Design
Retrospective propensity-matched cohort in the TriNetX federated records network, 2018-2024; matched pairs of 952-1,393 adults undergoing catheter ablation for atrial fibrillation
Verdict
New finding
Driver
Heart and stroke
Driver
Obesity, diabetes and GLP-1

Other drivers in Health today